Eyes on Systems Pharmacology – Development of a Disease-Modifying Therapy for Retinal Degenerations
Bidragets beskrivning
Retinal degenerative diseases are blinding conditions that generally lack preventive therapies. Particularly Age-related Macular Degeneration is a major healthcare burden. A treatment that would slow degeneration regardless of the underlying pathology could lead to satisfactory resolution fastest, especially if based on clinical drugs approved for use in other indications. I have spent several years in the USA working on a combinational drug treatment concept that capitalizes on drug repurposing. We have shown that the treatment is effective against retinal degeneration in many disease models. My intent is to continue this research in Finland. Specifically, I start working towards intraocularly administered therapy to minimize drug side effects. My aim is to develop the first clinical treatment to slow progression of retinal degeneration. The use of multiple cooperating drugs, repurposing and local administration in a single regimen would become an unprecedented medical advancement.
Visa merStartår
2021
Slutår
2026
Beviljade finansiering
Andra beslut
361972
Akademiforskarens forskningskostnader(2024)
200 000 €
346295
Akademiforskarens forskningskostnader(2021)
300 000 €
Finansiär
Finlands Akademi
Typ av finansiering
Akademiforskare
Utlysning
Övriga uppgifter
Finansieringsbeslutets nummer
339691
Vetenskapsområden
Farmaci
Forskningsområden
Farmasia
Identifierade teman
eyes, eye diseases